Description

Elbonix 50mg Tablets (Eltrombopag) – 28 Tablets | Imported in Pakistan

Product Name: Elbonix 50mg Tablets
Generic Name: Eltrombopag Olamine
Formulation: Oral Tablets
Pack Size: 28 Tablets
Availability: Imported in Pakistan

---

Product Overview

Elbonix 50mg Tablets contain Eltrombopag, a thrombopoietin receptor agonist widely prescribed for the treatment of low platelet counts in various blood-related conditions. It is primarily indicated for chronic immune thrombocytopenic purpura (ITP), thrombocytopenia associated with chronic Hepatitis C (HCV), and severe aplastic anemia. By stimulating platelet production in the bone marrow, Elbonix helps reduce the risk of bleeding and supports overall blood health.

---

Key Benefits

• Increases Platelet Count: Boosts platelet production to prevent excessive bleeding.

• Treatment for Chronic ITP: Effective in managing immune-related low platelet disorders.

• Support for Hepatitis C Patients: Helps maintain safe platelet levels during antiviral therapy.

• Severe Aplastic Anemia Management: Improves blood cell production in bone marrow failure conditions.

• Convenient Oral Dosage: Easy-to-take tablet formulation ensures better compliance.

---

How It Works

Eltrombopag in Elbonix acts as a thrombopoietin receptor agonist. It binds to the TPO receptor in bone marrow stem cells, stimulating the growth and differentiation of megakaryocytes – the precursor cells that form platelets. This results in improved platelet counts and reduced bleeding risks in patients with chronic blood disorders.

---

Indications

• Chronic Immune Thrombocytopenic Purpura (ITP)

• Thrombocytopenia due to Chronic Hepatitis C (HCV)

• Severe Aplastic Anemia

---

Dosage & Administration

• Chronic ITP: Usually started at 50mg once daily, with adjustments based on platelet counts.

• Hepatitis C-Related Thrombocytopenia: Starting dose 25mg once daily, maximum 100mg daily.

• Severe Aplastic Anemia: Up to 150mg daily depending on age and condition.

Dosage must always be prescribed and monitored by a healthcare professional.

---

Usage Instructions

• Take Elbonix on an empty stomach, at least 2 hours before or 4 hours after meals containing calcium, iron, magnesium, or zinc.

• Avoid antacids and mineral supplements close to dosing time.

• Swallow the tablet whole with water – do not crush or chew.

---

Safety Information & Precautions

• Liver Monitoring: Regular liver function tests are required, as Eltrombopag may cause elevated liver enzymes.

• Drug Interactions: Interacts with statins, anticoagulants, HIV medicines, and chemotherapy drugs. Inform your doctor about all current medications.

• Food Interactions: Dairy products, fortified cereals, and calcium-rich foods can reduce absorption.

• Medical Conditions: Caution in patients with liver disease, cataracts, or risk of blood clots.

• Storage: Keep at 15°C–30°C, away from heat and moisture, in the original packaging.

---

Possible Side Effects

• Headache or fatigue

• Nausea, vomiting, or diarrhea

• Increased liver enzymes (ALT/AST)

• Muscle pain or weakness (especially with statins)

• Rare: risk of blood clots or bone marrow fibrosis (long-term use)

---

Why Choose Elbonix (Eltrombopag)

• Imported and quality-assured formulation

• Effective platelet-boosting therapy for blood-related conditions

• Clinically proven to reduce bleeding risks in chronic ITP, HCV, and aplastic anemia

• Convenient oral therapy for long-term management